As pipeline molecules become increasingly complex, traditional ligand-binding assays may not always provide the level of characterization required. WuXi Biology’s...

As therapeutic modalities continue to expand beyond small molecules and monoclonal antibodies, one principle is becoming increasingly important in drug...

Matching the Right Target, Modality, and Patient: As oncology drug discovery becomes increasingly modality-rich and biologically complex, one question is...

How Integrating Chemistry and Biology Reshapes Early Drug Development: At the American Association for Cancer Research (AACR) Annual Meeting, the...

Small Molecule + Peptide DEL for Academia! WuXi Biology is pleased to introduce DELopen 5th Generation Screening Kit, with upgraded...

Expanded Diversity, Enhanced Screening Power: WuXi Biology is pleased to introduce PeptideDEL 2.0, our upgraded DNA-encoded peptide library designed to...

Dear customers and friends, As 2025 comes to a close, I hope you and your family had a wonderful year!...